Zimmer to Sell Notes – Analyst Blog
Source: http://www.zacks.com/stock/news/27288/Zimmer+to+Sell+Notes+-+Analyst+BlogPosted on Friday, November 13th, 2009 | In Investing Lessons, Stocks to Watch
Zimmer Holdings, Inc. (ZMH) recently decided to raise $1 billion by selling its senior unsecured notes in an underwritten public offering in two separate transactions. The transactions involve selling $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The public offering is expected to close on Nov 17, 2009.
Zimmer has already filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission for the public offer. Citigroup Global Markets Inc., a division of Citigroup, Inc. (C); Banc of America Securities LLC, a division of Bank of America Corp. (BAC); and J.P. Morgan Securities Inc., a division of JPMorgan Chase & Co. (JPM) are the active joint book-running managers of the offering. The offer will be made to the public through the prospectus.
The 2019 notes yield 118 basis points above the Treasury benchmark and the 2039 notes yield 135 basis points above the Treasury benchmark. Zimmer will use the net proceeds of the offering to repay its outstanding credit balance under its credit facility and for general corporate purposes like the company’s stock repurchase program. Zimmer already had cash and cash equivalents of roughly $440 million at the end of the third quarter of 2009.
Zimmer is a global leader in the design, development, manufacture, and marketing of reconstructive implants, and trauma and related orthopedic surgical products. The company competes in the orthopedic market with players like Stryker Corp. (SYK), Wright Medical (WMGI), and Smith & Nephew (SNN).
Read the full analyst report on “ZMH”
Read the full analyst report on “C”
Read the full analyst report on “BAC”
Read the full analyst report on “JPM”
Read the full analyst report on “SYK”
Read the full analyst report on “WMGI”
Read the full analyst report on “SNN”
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- Coventry Tops Zacks Consensus - Analyst Blog - February 9th, 2010
- W.R. Berkley Surpasses Estimates - Analyst Blog - February 9th, 2010
- Universal Forest Meets Loss Est - Analyst Blog - February 9th, 2010
- Biogen Beats & Guides Higher - Analyst Blog - February 9th, 2010
- Becton Recalls Catheters - Analyst Blog - February 9th, 2010
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.